Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Sandy Srinivas, Stanford University
ClinicalTrials.gov Identifier:
NCT00477087
First received: May 18, 2007
Last updated: July 3, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)